Multidrug-resistant Gram-negative bacteria: a product of globalization

The Journal of Hospital Infection
P M Hawkey

Abstract

Global trade and mobility of people has increased rapidly over the last 20 years. This has had profound consequences for the evolution and the movement of antibiotic resistance genes. There is increasing exposure of populations all around the world to resistant bacteria arising in the emerging economies. Arguably the most important development of the last two decades in the field of antibiotic resistance is the emergence and spread of extended-spectrum β-lactamases (ESBLs) of the CTX-M group. A consequence of the very high rates of ESBL production among Enterobacteriaceae in Asian countries is that there is a substantial use of carbapenem antibiotics, resulting in the emergence of plasmid-mediated resistance to carbapenems. This article reviews the emergence and spread of multidrug-resistant Gram-negative bacteria, focuses on three particular carbapenemases--imipenem carbapenemases, Klebsiella pneumoniae carbapenemase, and New Delhi metallo-β-lactamase--and highlights the importance of control of antibiotic use.

References

Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Aroonwadee ChanawongPeter Michael Hawkey
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Christel HumeniukAlain Philippon
May 21, 2008·Antimicrobial Agents and Chemotherapy·Björn A EspedidoJonathan R Iredell
Aug 19, 2009·The Journal of Antimicrobial Chemotherapy·Peter M Hawkey, Annie M Jones
Feb 4, 2010·Scandinavian Journal of Infectious Diseases·Johan ThamEva Melander
Dec 7, 2010·The Journal of Antimicrobial Chemotherapy·Yan QiYunsong Yu
Mar 24, 2011·Journal of Pain & Palliative Care Pharmacotherapy· Food And Drug Administration Public Health Service U S Department Of Health And Human Services
Feb 3, 2012·PloS One·Marie-Hélène Nicolas-ChanoineUNKNOWN Group Coli β
Mar 10, 2012·The Journal of Antimicrobial Chemotherapy·Nimal H WickramasinghePeter M Hawkey
Jan 26, 2013·The Lancet Infectious Diseases·Elizabeth M H WellingtonA Prysor Williams
Jun 14, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ali Faisal SaleemAnita K M Zaidi
Aug 7, 2013·Antimicrobial Agents and Chemotherapy·Paul-Louis WoertherAntoine Andremont
Aug 24, 2013·The Lancet Infectious Diseases·L Silvia Munoz-PriceJohn P Quinn
Nov 10, 2013·PloS One·Johanna HanefeldRichard Smith
Dec 7, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mitchell J Schwaber, Yehuda Carmeli
Dec 24, 2013·Médecine et maladies infectieuses·P Nordmann
Apr 30, 2014·American Journal of Infection Control·Zhi-chang ZhaoBin Li
May 7, 2014·The Journal of Antimicrobial Chemotherapy·G C A AmosE M Wellington
Aug 13, 2014·Annals of Clinical Microbiology and Antimicrobials·Sheng ChenPeiyuan Xia
Sep 11, 2014·The Journal of Antimicrobial Chemotherapy·Amos AdlerUNKNOWN Post-Acute-Care Hospital Carbapenem-Resistant Enterobacteriaceae Working Group
Oct 12, 2014·Trends in Microbiology·Liang ChenBarry N Kreiswirth

❮ Previous
Next ❯

Citations

Mar 19, 2016·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·İsmail Hakkı Tekiner, Haydar Özpınar
Mar 17, 2015·The Journal of Hospital Infection·A M Walker
Jun 18, 2016·Diagnostic Microbiology and Infectious Disease·Joseane Cristina FerreiraAna Lúcia Costa Darini
Sep 30, 2016·Frontiers in Microbiology·Daniela Jones-DiasManuela Caniça
Oct 19, 2016·Journal of Hepatology·Javier FernándezMarie-Hélène Nicolas-Chanoine
Mar 16, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Carla CaliaRosa Monno
Jul 16, 2015·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·S C L Pereira, M C D Vanetti
Apr 26, 2017·Journal of Global Antimicrobial Resistance·Amornrat ThuengernKrit Thirapanmethee
Jul 28, 2017·Metallomics : Integrated Biometal Science·Marcelo Monteiro PedrosoGerhard Schenk
Mar 15, 2018·Journal of the International Association of Providers of AIDS Care·Kennedy Daniel Mwambete, Mathias Eulambius
Sep 30, 2016·Microorganisms·Jocelyn Qi Min TeoAndrea Lay-Hoon Kwa
Aug 8, 2018·The Journal of Antimicrobial Chemotherapy·Peter M Hawkey
May 13, 2020·Expert Review of Anti-infective Therapy·Zikria SaleemTahir Mehmood Khan
Oct 14, 2016·Chinese Medical Sciences Journal = Chung-kuo I Hsüeh K'o Hsüeh Tsa Chih·Wei ChenQin Ou
Dec 28, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J A BielickiUNKNOWN ARPEC project
Jun 27, 2018·Antimicrobial Agents and Chemotherapy·Fabrice CompainMichel Arthur
Nov 7, 2019·Antimicrobial Resistance and Infection Control·Oumar Ouchar MahamatSylvain Godreuil
Mar 3, 2017·BMC Infectious Diseases·Michael PritschAndreas Wieser
Sep 2, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jérôme Bataille, Philippe Brouqui
May 26, 2017·The Journal of Antimicrobial Chemotherapy·Edward R BevanPeter M Hawkey
Dec 12, 2018·Annals of Clinical Microbiology and Antimicrobials·Edwin Barrios-VillaRosa Del Carmen Rocha-Gracia
Dec 14, 2018·Scientific Reports·B B A RaymondS P Djordjevic
Nov 14, 2019·Expert Review of Anti-infective Therapy·Abdullah Tarık Aslan, Murat Akova
Oct 28, 2019·PloS One·Alodia GirmaRosemary C She
May 17, 2017·Antimicrobial Resistance and Infection Control·E TartariA Voss
Sep 5, 2019·Singapore Medical Journal·Alvin Qijia ChuaLi Yang Hsu
Sep 24, 2020·International Journal of Microbiology·Birhan AlemnewMelese Abate Reta
Apr 5, 2017·The Journal of Infectious Diseases·Christopher S HenryMark J Mandel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Related Papers

The Lancet Infectious Diseases
Stephan GöttigVolkhard Aj Kempf
The Lancet Infectious Diseases
Anette M HammerumKurt Fuursted
The Lancet Infectious Diseases
Tse Hsien KohTse Yuen Koh
The Lancet Infectious Diseases
Pierre BogaertsYouri Glupczynski
© 2022 Meta ULC. All rights reserved